Clinical Trials Browser

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

NCT05894954 2026-02-18

EVANTHEA

Phase 3 Completed

73 enrolled

Lymphoid

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05230758 2026-01-22

Met Med Can

Phase 3 Recruiting

140 enrolled

CNS

Medulloblastoma, Cognitive Dysfunction

NCT06950190 2025-08-12

(ECCPC)

Phase 3 Enrolling by invitation

100 enrolled

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

NCT02360215 2025-04-23

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

Phase 3 Completed

518 enrolled 40 charts

CNS

Brain Neoplasms, Cognitive Dysfunction

NCT04395339 2024-08-01

GLORY

Phase 3 Terminated

51 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Gangliosidoses, Radiation Injuries, Gangliosidosis, GM1, Cognitive Dysfunction

NCT02822573 2023-09-13

Remember

Phase 3 Completed

276 enrolled 33 charts

Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

NCT02350738 2015-07-28

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Phase 3 Completed

64 enrolled

Lymphoid

Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT00884338 2009-12-21

Cognitive Function After Stem Cell Transplantation

Phase 3 Unknown

60 enrolled

Fatigue, Motor Activity, Neoplasms, Cognitive Dysfunction

Clinical Trials

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

EVANTHEA

Met Med Can

(ECCPC)

Memantine Hydrochloride and Whole-Brain Radiotherapy With or Without Hippocampal Avoidance in Reducing Neurocognitive Decline in Patients With Brain Metastases

GLORY

Remember

Effects of Multimodal Cognitive Enhancement Therapy (MCET) for Ealy Dementia

Cognitive Function After Stem Cell Transplantation